UPDATED Aug 24, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALNY | US$454.38 | -0.5% | 68.8% | US$59.6b | US$424.64 | PS24.2x | E54.1% | n/a | ||
VSTM | US$9.08 | 13.9% | 247.9% | US$558.8m | US$15.13 | PS261.5x | E54.0% | n/a | ||
688356 | CN¥98.52 | -3.4% | 97.4% | CN¥5.8b | n/a | PE218.6x | E54.0% | 0.2% | ||
IMCR | US$32.93 | 1.9% | -10.8% | US$1.7b | US$62.20 | PS4.7x | E53.7% | n/a | ||
688293 | CN¥58.27 | 2.5% | 116.9% | CN¥6.3b | n/a | PE409.9x | E53.6% | 0.7% | ||
FARN | UK£2.25 | 3.4% | 30.1% | UK£251.9m | UK£10.13 | PE-11.2x | E53.2% | n/a | ||
GOSS | US$2.34 | 17.6% | 153.3% | US$532.1m | US$7.75 | PS13.2x | E53.0% | n/a | ||
YCBD | US$0.67 | -1.5% | -84.8% | US$6.0m | US$2.00 | PB1x | E53.0% | n/a | ||
524558 | ₹13,543.50 | 0.06% | 13.6% | ₹177.9b | ₹15,712.50 | PE98.7x | E52.8% | 0.09% | ||
EVAX | US$3.25 | 0.9% | -78.9% | US$20.5m | US$13.25 | PS6.5x | E52.4% | n/a | ||
ETTX | US$2.19 | 0% | -14.8% | US$104.8m | US$2.00 | PB6.3x | E52.3% | n/a | ||
AYTU | US$2.20 | 0% | -7.2% | US$19.7m | US$9.67 | PB0.6x | E52.2% | n/a | ||
1521 | HK$1.44 | -6.5% | 118.2% | HK$2.9b | HK$1.10 | PE471.8x | E51.9% | n/a | ||
AQST | US$3.98 | -4.8% | -10.6% | US$481.5m | US$8.42 | PS10.9x | E51.8% | n/a | ||
MNPR | US$32.06 | -6.4% | 1,123.7% | US$197.8m | US$62.18 | PB3.8x | E51.4% | n/a | ||
SRPT | US$20.22 | -3.7% | -85.6% | US$2.0b | US$23.92 | PB1.5x | E51.3% | n/a | ||
XGN | US$10.10 | 3.6% | 227.9% | US$222.2m | US$11.17 | PS3.8x | E51.2% | n/a | ||
BIOCON | ₹359.95 | -1.2% | 1.9% | ₹479.7b | ₹382.90 | PE124.8x | E51.2% | 0.1% | ||
SRRK | US$35.49 | 12.6% | 276.8% | US$3.4b | US$50.00 | PB14.6x | E51.1% | n/a | ||
GTBP | US$1.11 | -25.3% | -48.6% | US$3.9m | US$11.00 | PB1.4x | E51.1% | n/a | ||
MNMD | US$10.19 | 4.5% | 66.5% | US$775.3m | US$25.00 | PB4.2x | E51.1% | n/a | ||
524735 | ₹256.30 | -0.5% | -21.1% | ₹31.4b | ₹390.00 | PE49.9x | E51.0% | 0.6% | ||
COGT | US$12.12 | 0.08% | 17.7% | US$1.7b | US$20.09 | PB36x | E50.9% | n/a | ||
ETON | US$17.30 | 5.7% | 282.7% | US$463.9m | US$30.00 | PS8x | E50.7% | n/a |